Home > Name List By n > N-[4-cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorophenyl)sulfonyl-2- hydroxy-2-methylpropanamide

CAS No 90357-06-5 , N-[4-cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorophenyl)sulfonyl-2-
hydroxy-2-methylpropanamide

  • Name: N-[4-cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorophenyl)sulfonyl-2-
    hydroxy-2-methylpropanamide
  • Synonyms: ICI 176334; Kalumid;N-[4-cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorophenyl)sulfonyl-2-
    hydroxy-2-methylpropanamide; 90357-06-5; Calutide; Cosudex; ICI-176334;Casodex;
  • CAS Registry Number:
  • Transport: OTH
  • Melting Point: 191-193 ºC
  • Density: 1.52 g/cm3
  • Refractive index: 1.577
  • Water Solubility: Insoluble in water
  • Safety Statements: 26-36
  • Hazard Symbols: Xi: Irritant;
  • Molecular Weight: 430.373373
  • InchiKey: LKJPYSCBVHEWIU-UHFFFAOYSA-N
  • InChI: InChI=1S/C18H14F4N2O4S/c1-17(26,10-29(27,
    28)14-6-3-12(19)4-7-14)16(25)24-13-5-2-11(9-23)15(8-13)18(20,21)22/h2-8,
    26H,10H2,1H3,(H,24,25)
  • Risk Statements: 36/37/38
  • Molecular Formula: C18H14F4N2O4S
  • Molecular Structure:CAS No:90357-06-5 N-[4-cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorophenyl)sulfonyl-2-<br />hydroxy-2-methylpropanamide
Search by region :

Select to

90357-06-5 Bicalutamide

  • China Advan Pharmachem Co., Ltd. [Manufacturers]
  • Tel: +86-(21)-6875-3906, 5058-1635
  • Fax: +86-(21)-5831-8593
  • Address: Room 1418 YuAn Mansion, No.738 Dongfang Road, Pu Dong, Shanghai, shanghai,shanghaiChina
Contact Supplier

90357-06-5 Bicalutamide

  • China lerison co.,ltd [Manufacturers]
  • Tel: 86-310-8579376
  • Fax: 86-310-8579377
  • Address: hebei province, china handan,hebeiChina
Contact Supplier

90357-06-5 Bicalutamide

Contact Supplier

90357-06-5 Bicalutamide

Contact Supplier

90357-06-5 Bicalutamide

  • Bicalutamide, 99%
  • China Sunshine Pharmaceutical Group [Manufacturer]
  • Tel: 86 10 63813532
  • Fax: 86 10 63854028
  • Address: B,Yuntongxing Business Buiding, No.57 East Street, Fengtai Zone, Beijing,China100071 BeijingCHINA Beijing,nullChina
Contact Supplier

90357-06-5 BICALUTAMIDE-D4

  • Canada TLC PharmaChem., Inc. [Manufacturer]
  • Tel: 905-760-1098
  • Fax: 905-760-2098
  • Address: TLC PharmaChem., Inc.
    5-150 Connie Crescent
    Concord, Ontario
    L4K 1L9, Canada null,nullCanada
Contact Supplier

90357-06-5 Bicalutamide

Contact Supplier

90357-06-5 Bicalutamide

  • Bicalutamide, >98%
  • United Kingdom KEMPROTEC Limited [Manufacturers]
  • Tel: +44 1642 591764
  • Fax: +44 1845 550001
  • Address: Middlesbrough, United Kingdom. Middlesbrough,MiddlesbroughUnited Kingdom
Contact Supplier

90357-06-5 BICALUTAMIDE

  • China Taizhou Creating Chemical Co.,Ltd [Manufacturer]
  • Tel: +86-576-88827176/ +86-576-88820069
  • Fax: +86-576-88822496
  • Address: B Suite 12F,
    Jiangbin Building,Jiaojiang,Taizhou,
    Zhejiang China null,nullChina
Contact Supplier

90357-06-5 Bicalutamide

  • China Hangzhou Heta Pharm & Chem Co., Ltd. [Manufacturers]
  • Tel: +86-(571)-88298791
  • Fax: +86-(571)-89937386
  • Address: 8# Xiyuan no.1 Road , Westlake Technologe Park, Sandun, Hangzhou 310030, Hangzhou,ZhejiangChina
Contact Supplier

Select to

References of N-[4-cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorophenyl)sulfonyl-2-
hydroxy-2-methylpropanamide
Title: Bicalutamide
CAS Registry Number: 90357-06-5
CAS Name: N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropanamide
Synonyms: 4-cyano-3-trifluoromethyl-N-(3-p-fluorophenylsulfonyl-2-hydroxy-2-methylpropionyl)aniline; (±)-4¢-cyano-a,a,a-trifluoro-3-[(p-fluorophenyl)sulfonyl]-2-methyl-m-lactotoluidide
Manufacturers' Codes: ICI-176334
Trademarks: Casodex (AstraZeneca)
Molecular Formula: C18H14F4N2O4S
Molecular Weight: 430.37
Percent Composition: C 50.23%, H 3.28%, F 17.66%, N 6.51%, O 14.87%, S 7.45%
Literature References: Non-steroidal peripherally active antiandrogen. Prepn: H. Tucker, EP 100172; idem, US 4636505 (1984, 1987 both to ICI); and structure-activity: H. Tucker et al., J. Med. Chem. 31, 954 (1988). Resolution and activity of enantiomers: H. Tucker, G. J. Chesterson, ibid. 885. Pharmacokinetics: I. D. Cockshott et al., Eur. Urol. 18, Suppl. 3, 10 (1990). Clinical trials in prostate cancer: G. Lunglmayr, Horm. Res. 32, Suppl. 1, 77 (1989); D. W. W. Newling, Eur. Urol. 18 Suppl. 3, 18 (1990). Review of pharmacology: B. J. A. Furr in Hormonal Therapy of Prostatic Diseases: Basic and Clinical Aspects, M. Motta, M. Serio, Eds. (Mediocom Europe, Milan, 1987) 148-161.
Properties: Crystals from a 1:1 (v/v) mix of ethyl acetate and petroleum ether, mp 191-193°.
Melting point: mp 191-193°
Therap-Cat: Antiandrogen; antineoplastic (hormonal).
Keywords: Antiandrogen; Antineoplastic (Hormonal); Antiandrogens.